For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period.
The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artemisinin. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artemisinin market.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Key Features:
The report on Artemisinin market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artemisinin market. It may include historical data, market Segmentation by Type (e.g., Extraction From Artemisia Annua, Semisynthetic Artemisinin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artemisinin market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artemisinin market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artemisinin industry. This include advancements in Artemisinin technology, Artemisinin new entrants, Artemisinin new investment, and other innovations that are shaping the future of Artemisinin.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artemisinin market. It includes factors influencing customer ' purchasing decisions, preferences for Artemisinin product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artemisinin market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artemisinin market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artemisinin market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artemisinin industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artemisinin market.
Market Segmentation:
Artemisinin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Extraction From Artemisia Annua
- Semisynthetic Artemisinin
Segmentation by application
- Antimalarial Injections
- Antimalarial Tablets
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Sanofi
- KPC Pharmaceuticals
- Kerui nanhai
- Guangxi xiancaotang
- Guilin Pharmaceutical
- Natural Bio-engineering
- BIONEXX
- CAT KHANH
- BEEPZ
- Novanat Bioresource
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artemisinin market?
What factors are driving Artemisinin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinin market opportunities vary by end market size?
How does Artemisinin break out type, application?